Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.
A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C. Gastroenterology. 2009 May; 136(5):1796-805.e6.
View in:
PubMed
subject areas
Antiviral Agents
Cells, Cultured
Female
Genotype
Hepacivirus
Hepatitis C, Chronic
Humans
Interferon Type I
Intracellular Signaling Peptides and Proteins
Male
Middle Aged
Polymorphism, Single Nucleotide
Treatment Outcome
authors with profiles
Yusuke Nakamura